Journals / Kocatepe Tıp Dergisi / 2026 / Cilt: 27 Sayı: 1

REPRODUCTIVE HEALTH AND MICROBIOTA: TRADITIONAL REVIEW

ÜREME SAĞLIĞI VE MİKROBİYOTA: GELENEKSEL DERLEME

Safiye Temel(AMASYA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ)0000-0001-5287-7347
Zeynep Büyük(AMASYA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ ENSTİTÜSÜ)0009-0007-0084-4309
Pages
144–156
Publication Date
2026-01-12
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The findings support that maintaining a healthy microbiota, monitoring and improving microbial changes will help manage reproductive diseases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Reproductive problems continue to increase day by day with changing environmental conditions and technological advances.
📊
Key Findings & Data:The decrease or increase in the diversity of Lactobacilli in a certain region under the influence of these factors causes disruptions in the microbiota balance, called dysbiosis.
💡
Conclusion & Impact:The findings support that maintaining a healthy microbiota, monitoring and improving microbial changes will help manage reproductive diseases.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Üreme sağlığı · mikrobiyota · kadın

Abstract

Reproductive problems continue to increase day by day with changing environmental conditions and technological advances. Simultaneously, there is increasing interest in the relationship between reproductive health and microbiota. In the human body, stable microbiota communities exist in the intestine, vagina, uterus, follicular fluid, testicles and semen. The microbiota component can be affected by many environmental and individual factors. The decrease or increase in the diversity of Lactobacilli in a certain region under the influence of these factors causes disruptions in the microbiota balance, called dysbiosis. Thus, the individuals' susceptibility to diseases increases. In particular, dysbiosis related to the intestinal and reproductive system causes gynecological and urogenital problems, from simple reproductive system infections to extremely serious cancers. It primarily causes fertility-related problems in men and women by disrupting the quality of gametes, and in the ongoing process, it negatively affects pregnancy, birth, and postpartum maternal and newborn health. Therefore, maintaining a healthy microbiota is important in protecting individuals from pathogens, increasing reproductive potential, and reducing adverse paternal, maternal, and neonatal outcomes. As a result, in this review, the microbiota in male and female reproductive systems is discussed with a holistic approach. Factors affecting the microbiota component, the important effects of microbiota on some gynecological problems such as sexually transmitted and non-transmitted diseases, endometrial polyp, endometriosis, endometritis, polycystic ovary syndrome, cervical cancer and endometrial cancer, as well as pregnancy, birth, postpartum period, newborn and breast milk in women; reproductive system problems and spermatogenesis processes in male, as well as on infertility in relation to both genders, and applications for microbiota in the prevention, monitoring and treatment of reproductive system disorders are explained. The findings support that maintaining a healthy microbiota, monitoring and improving microbial changes will help manage reproductive diseases.

Özet

Değişen çevresel koşullar ve teknolojik ilerlemelerle birlikte üremeye ilişkin sorunlar her geçen gün artmaya devam etmektedir. Eş zamanlı olarak, üreme sağlığı ile mikrobiyota arasındaki ilişkiye olan ilgi de giderek artmaktadır. İnsan vücudunda bağırsak, vajina, uterus, foliküler sıvı, testisler ve semende stabil mikrobiyota toplulukları bulunmaktadır. Mikrobiyota bileşenini ise birçok çevresel ve bireysel faktör etkileyebilmektedir. Bu faktörlerin etkisiyle belirli bir bölgedeki Laktobasillerin çeşitliliğindeki azalma veya artma disbiyozis olarak adlandırılan mikrobiyota dengesinde bozulmalara neden olmaktadır. Böylelikle bireyin hastalıklara olan duyarlılığı artmaktadır. Özellikle, bağırsak ve üreme sistemine ilişkin disbiyozlar, basit üreme sistemi enfeksiyonlarından kanserlere kadar son derece ciddi jinekolojik ve ürogenital sorunlara yol açmaktadır. Kadın ve erkekte, gamet kalitesini bozarak en başta fertilite ile ilgili sorunlara neden olmakta, devam eden süreçte ise gebeliği, doğumu, doğum sonu anne ve yenidoğan sağlığını olumsuz yönde etkilemektedir. Bu nedenle, sağlıklı bir mikrobiyotanın sürdürülmesi, bireyleri patojenlerden korumada, üreme potansiyelini arttırmada ve olumsuz paternal, maternal ve yenidoğan sonuçlarını azaltmada önemlidir. Sonuç olarak, bu derlemede kadın ve erkek üreme sistemlerinde mikrobiyota holistik bir yaklaşımla tartışılmaktadır. Mikrobiyota bileşenini etkileyen faktörler, mikrobiyotanın kadında cinsel yolla bulaşan ve bulaşmayan hastalıklar, endometrial polip, endometriozis, endometrit, polikistik over sendromu, servikal kanser ve endometrial kanser gibi bazı jinekolojik sorunlar ile gebelik, doğum, doğum sonu dönem, yenidoğan ve anne sütü üzerinde; erkekte üreme sistemi sorunları ve spermatogenez sürecinde, ayrıca her iki cinsiyetle ilişkili olarak infertilite üzerinde önemli etkileri ve üreme sistemine ilişkin bozukluklarının önlenmesi, izlenmesi ve tedavisinde mikrobiyotaya yönelik uygulamalar açıklanmaktadır. Bulgular, sağlıklı mikrobiyotanın korunmasının, mikrobiyal değişikliklerin izlenmesinin ve iyileştirilmesinin üreme hastalıklarının yönetilmesine yardımcı olacağını desteklemektedir.

🔖

Cite This Article

Temel, S., Büyük, Z. (2026). REPRODUCTIVE HEALTH AND MICROBIOTA: TRADITIONAL REVIEW. Kocatepe Tıp Dergisi, Cilt: 27 Sayı: 1, 144–156. https://doi.org/10.18229/kocatepetip.1585741

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (66)

  1. Nacar G, Timur S. Kadın sağlığı ve mikrobiyota. Kadın Sağlığı Hemşireliği Dergisi. 2021;7(1):48-70.
  2. Alonzo Martínez MC, Cazorla E, Cánovas E, et al. Study of the vaginal microbiota in healthy women of reproductive age. Microorganisms. 2021;9(5):1069.
  3. Chen X, Lu Y, Chen T, Li R. The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol. 2021;11:631972.
  4. Wang N, Chen L, Yi K, et al. The effects of microbiota on reproductive health: a review. Crit Rev Food Sci Nutr. 2024;64(6):1486-507.
  5. Miller EA, Beasley DE, Dunn RR, Archie EA. Lactobacilli dominance and vaginal pH: why is the human vaginal microbiome unique? Front Microbiol. 2016;7:224527.
  6. Cherpes TL, Hillier SL, Meyn LA, et al. A delicate balance: risk factors for acquisition of bacterial vaginosis include sexual activity, absence of hydrogen peroxide-producing lactobacilli, black race, and positive herpes simplex virus type 2 serology. ASTDA. 2008;35(1):78-83.
  7. Willing BP, Russel SL, Finlay BB. Shifting the balance: antibiotic effects on host–microbiota mutualism. Nat Rev Microbiol. 2011;9(4):233-43.
  8. Witkin SS, Linhares IM. Why do lactobacilli dominate the human vaginal microbiota? BJOG. 2017;124(4):606-11.
  9. Brooks JP, Edwards DJ, Blithe DL, et al. Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome. Contraception. 2017;95(4):405-13.
  10. Gupta P, Sing MP, Goyal K. Diversity of vaginal microbiome in pregnancy: deciphering the obscurity. Front Public Health. 2020;8:326.
  11. Cong X, Xu W, Janton S, et al. Gut microbiome developmental patterns in early life of preterm infants: impacts of feeding and gender. PLoS One. 2016;11(4):e0152751.
  12. Wang J, Li Z, Ma X, et al. Translocation of vaginal microbiota is involved in impairment and protection of uterine health. Nat Commun. 2021;12(1):4191.
  13. Brotman RM, Shardell MD, Gajer P, et al. Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause. 2014;21(5):450-8.
  14. Pascottini OB, Spricigo JFW, Van Schyndel SJ, et al. Effects of parity, blood progesterone, and non-steroidal anti-inflammatory treatment on the dynamics of the uterine microbiota of healthy postpartum dairy cows. PLoS One. 2021;16(2):1-17.
  15. Si J, You HJ, Yu J, Sung J, Ko GP. Prevotella as a hub for vaginal microbiota under the ınfluence of host genetics and their association with obesity. Cell Host Microbe. 2017;21(1):97-105.
  16. Barczyński B, Frąszczak K, Grywalska E, et al. Vaginal and cervical microbiota composition in patients with endometrial cancer. Int J Mol Sci. 2023;24:8266.
  17. Farahani L, Tharakan T, Yap T, et al. S. The semen microbiome and its impact on sperm function and male fertility: a systematic review and meta‐analysis. Andrology. 2021;9(1):115-44.
  18. Gu Y, Zhou G, Zhou F, et al. Gut and vaginal microbiomes in PCOS: Implications for women’s health. Front Endocrinol (Lausanne). 2022;13:808508.
  19. Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020;19:1-19.
  20. Muzii L, Galati G, Mattei G, et al. The role of microbiota in female fertility and infertility. Minerva Obstet Gynecol. 2022;74(5):419-33.
  21. Zhu B, Tao Z, Edupuganti L, et al. Roles of the microbiota of the female reproductive tract in gynecological and reproductive health. Microbiol Mol Biol Rev. 2022;86(4):e00181-21.
  22. Chen X, Li P, Liu M, et al. Gut dysbiosis induces the development of pre-eclampsia through bacterial translocation. Gut. 2020;69(3):513-22.
  23. Durğut S, Yağmur Y. Mikrobiyotanın kadın ve çocuk sağlığına etkisi. Ege Üniversitesi Hemşirelik Bilimleri Dergisi. 2020;36(3):207-16.
  24. Moreno I, Simon C. Deciphering the effect of reproductive tract microbiota on human reproduction. Reprod Med Biol. 2019;18(1):40-50.
  25. Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest. 2011;121(12):4610-7.
  26. Wu M, Li H, Yu H, et al. Disturbances of vaginal microbiome composition in human papillomavirus infection and cervical carcinogenesis: a qualitative systematic review. Front Oncol. 2022;12:941741.
  27. Zhou ZW, Long HZ, Cheng Y, et al. From microbiome to inflammation: the key drivers of cervical cancer. Front Microbiol. 2021;12:767931.
  28. Giampaolino P, Foreste V, Di Filippo C, et al. Microbiome and PCOS: State-of-art and future aspects. Int J Mol Sci. 2021;22(4):1-16.
  29. Fang RL, Chen LX, Shu WS, et al. Barcoded sequencing reveals diverse intrauterine microbiomes in patients suffering with endometrial polyps. Am J Transl Res. 2016;8(3):1581-92.
  30. Stapleton AE. The vaginal microbiota and urinary tract infection. Microbiol Spectr. 2016;4(6):10.1128.
  31. Van De Wijgert JHHM, Verwijs MC, Agaba SK, et al. Intermittent lactobacilli-containing vaginal probiotic or metronidazole use to prevent bacterial vaginosis recurrence: a pilot study incorporating microscopy and sequencing. Sci Rep. 2020;10(1):3884.
  32. Nandi D, Parida S, Sharma D. The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful! Gut Microbes. 2023;15(1):2221452.
  33. Walsh DM, Hokenstad AN, Chen J, et al. Postmenopause as a key factor in the composition of the endometrial cancer microbiome (ECbiome). Sci Rep. 2019;9(1):1-16.
  34. Ma Z, Qu M, Wang X. Analysis of gut microbiota in patients with breast cancer and benign breast lesions. Pol J Microbiol. 2022;71(2):217-26.
  35. Moreno I, Codoñer FM, Vilella F, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703.
  36. Jeong H, Han SJ, Yoo HN, et al. Comparison of changes in etiologic microorganisms causing early-onset neonatal sepsis between preterm labor and preterm premature rupture of membranes. J Matern Fetal Med. 2015;28(16):1923-8.
  37. Gudnadottir U, Debelius JW, Du J, et al. The vaginal microbiome and the risk of preterm birth: a systematic review and network meta-analysis. Sci Rep. 2022;12(1):7926.
  38. Aktaş S, Derya YA, Toker E, (editörler). A’dan Z’ye Temel Ebelik. In: Kırca AŞ, Güdücü N. Kadın sağlığı ve mikrobiyota. 1nci Baskı, İstanbul: Medikal Sağlık ve Yayıncılık, 2023:851-62.
  39. Avershina E, Slangsvold S, Simpson MR, et al. Diversity of vaginal microbiota increases by the time of labor onset. Sci Rep. 2017;7(1):1-7.
  40. Ferretti P, Pasolli E, Tett A, et al. Mother-to-ınfant microbial transmission from different body sites shapes the developing ınfant gut microbiome. Cell Host Microbe. 2018;24(1):133-45.e5.
  41. Haahr T, Glavind J, Axelsson P, et al. Vaginal seeding or vaginal microbial transfer from the mother to the caesarean-born neonate: a commentary regarding clinical management. BJOG. 2018;125(5):533-6.
  42. Sakwinska O, Foata F, Berger B, et al. Does the maternal vaginal microbiota play a role in seeding the microbiota of neonatal gut and nose? Benef Microbes. 2017;8(5):763-78.
  43. Chua MC, Ben-Amor K, Lay C, et al. Effect of synbiotic on the gut microbiota of cesarean delivered ınfants. J Pediatr Gastroenterol Nutr. 2017;65(1):102-6.
  44. Doğanay D, Özkan BC. Anne, bebek ve mikrobiyota. Biruni Sağlık ve Eğitim Bilimleri Dergisi. 2021;7:4-9.
  45. Mueller NT, Differding MK, Sun H, et al. Maternal bacterial engraftment in multiple body sites of cesarean section born neonates after vaginal seeding-a randomized controlled trial. mBio. 2023;14(3):e00491-23.
  46. Shao Y, Forster SC, Tsaliki E, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574(7776):117-21.
  47. Hu JH, Sheng J, Guo HM, et al. Association between labor epidural analgesia and gut microbiota: a prospective cohort study. Heliyon. 2024;10(9):e29883.
  48. Weerasuriya W, Saunders JE, Markel L, et al. Maternal gut microbiota in the postpartum period: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2023;285:130-47.
  49. Escobar MF, Hincapie MA, Barona JS. Immunological role of the maternal uterine microbiota in postpartum hemorrhage. Front Immunol. 2020;11:504.
  50. Farhana M, Tamura N, Mukai M, et al. Histological characteristics of the myometrium in the postpartum hemorrhage of unknown etiology: a possible involvement of local immune reactions. J Reprod Immunol. 2015;110:74-80.
  51. Mutic AD, Jordan S, Edwards SM, et al. The postpartum maternal and newborn microbiomes. MCN Am J Matern Child Nurs. 2017;42(6):326-31.
  52. Stinson LF, Payne MS, Keelan JA. A critical review of the bacterial baptism hypothesis and the impact of cesarean delivery on the infant microbiome. Front Med (Lausanne). 2018;5:135.
  53. Healy DB, Ryan CA, Ross RP, et al. Clinical implications of preterm infant gut microbiome development. Nat Microbiol. 2022;7(1):22-33.
  54. Nuzzi G, Trambusti I, DI Cicco ME, et al. Breast milk: more than just nutrition! Minerva Pediatr (Torino). 2021;73(2):111-4.
  55. Ito M, Tanaka M, Date M, et al. Microbiota in human breast milk: Noninfectious mastitis versus without mastitis. Pediatr Int. 2023;65(1):e15677.
  56. Alfano M, Ferrarese R, Locatelli I, et al. Testicular microbiome in azoospermic men’first evidence of the impact of an altered microenvironment. Hum Reprod. 2018;33(7):1212-7.
  57. Ding N, Zhang X, Zhang XD, et al. Impairment of spermatogenesis and sperm motility by the high-fat diet- induced dysbiosis of gut microbes. Gut. 2020;69(9):1608-19.
  58. de Almeida Gomes I, Monteiro PB, de Moura GA, et al. Microbiota and seminal quality: a systematic review. JBRA Assist Reprod. 2023;27(3):507.
  59. Zhang T, Sun P, Geng Q, et al. Disrupted spermatogenesis in a metabolic syndrome model: The role of vitamin a metabolism in the gut–testis axis. Gut. 2022;71(1):78-87.
  60. Zhang P, Feng Y, Li L, et al. Improvement in sperm quality and spermatogenesis following faecal microbiota transplantation from alginate oligosaccharide dosed mice. Gut. 2021;70(1):222-5.
  61. de Souza SV, Monteiro PB, de Moura GA, et al. Vaginal microbioma and the presence of lactobacillus spp. as interferences in female fertility: a review system. JBRA Assist Reprod. 2023;27(3):496.
  62. Aslan K, Kasapoğlu I, Kuşpınar G, ve ark. Luteal fazda vajinal laktobasil desteğinin IVF/ICSI sikluslarında taze embriyo transferi uygulanan hastalarda implantasyon oranlarına etkisi. Uludağ Üniversitesi Tıp Fakültesi Dergisi. 2020;46(2):177-80.
  63. Tanha FD, Rahmani Z, Razaei Z, et al. The effect of normalizing vaginal microbiome using lactovag in improving pregnancy outcomes in frozen embryo transfer cycles: a randomized clinical trial. Arch Gynecol Obstet. 2023;308(5):1587-92.
  64. Wu J, Zhuo Y, Liu Y, et al. Association between premature ovarian insufficiency and gut microbiota. BMC PC.2021;21(1):418.
  65. Öngen M, Kırca N, Boz İ. İnfertilite ve mikrobiyota arasındaki ilişki üzerine bir literatür derleme. Jinekoloji- Obstetrik ve Neonatoloji Tıp Dergisi. 2020;17(3):478-82.
  66. Balci EG. Yenidoğan bağırsak mikrobiyotasına etki eden faktörler. Hemşirelik Bilimi Dergisi. 2021;4(13):156-62.